デフォルト表紙
市場調査レポート
商品コード
1467557

がん分子診断市場レポート:がんタイプ、製品、技術、エンドユーザー、地域別、2024~2032年

Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 137 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
がん分子診断市場レポート:がんタイプ、製品、技術、エンドユーザー、地域別、2024~2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん分子診断市場規模は2023年に42億米ドルに達しました。今後、IMARC Groupは、同市場が2032年までに131億米ドルに達し、2024~2032年の間に13%の成長率(CAGR)を示すと予測しています。

がん分子診断は、がん細胞の生物学的分子を分析することにより、がん細胞の存在を特定します。DNA、RNA、細胞タンパク質中の特定の遺伝子配列を検出・測定するために、血液、唾液、腫瘍組織サンプルに対していくつかの試験が実施されます。がん分子診断は、迅速な分析に役立ち、がんの個別化治療に活用される詳細な情報を記載しています。これらの診断ソリューションは、がんの早期発見のための臨床試験やポイントオブケア(POC)試験に応用されています。また、血液バンクでは、提供された血液サンプルに存在する病原体や感染症を特定するためにも使用されています。

ライフスタイルの変化、高齢者人口の増加、喫煙の増加傾向に起因するがんの有病率の上昇は、世界のがん分子診断市場の成長を促す主要な要因の一つです。これとは別に、次世代シーケンシング(NGS)技術の進歩とともに、迅速かつ正確な診断に対する需要の高まりが、市場の成長に寄与しています。さらに、ウイルスや細菌感染症に罹患する人の増加や献血キャンペーンへの参加の増加が、世界の腫瘍分子診断需要にプラスの影響を与えています。しかし、コロナウイルス感染症(COVID-19)の突然の流行により、いくつかの医療機関は受診回数を減らすことで、がん患者へのパンデミックのリスクを軽減する措置を講じています。さらに、COVID-19試験のために診断リソースを再利用し、その結果腫瘍学的試験が減少したため、がん患者の定期検診が減少しています。

本レポートで扱う主要質問

  • 世界のがん分子診断市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • COVID-19が世界のがん分子診断市場に与えた影響は?
  • 主要な地域市場は?
  • がんタイプ別の市場内訳は?
  • 製品別の市場内訳は?
  • 技術別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主要促進要因と課題は何か?
  • 世界のがん分子診断市場の構造と主要参入企業は?
  • 業界における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 がん分子診断の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:がんタイプ別

  • 乳がん
  • 前立腺がん
  • 大腸がん
  • 子宮頸がん
  • 肝臓がん
  • 肺がん
  • 血液がん
  • その他

第7章 市場内訳:製品別

  • 装置
  • 試薬
  • その他

第8章 市場内訳:技術別

  • ポリメラーゼ連鎖反応(PCR)
  • in situハイブリダイゼーション
  • チップとマイクロアレイ
  • 等温核酸増幅技術(INAAT)
  • 質量分析
  • DNAとNGSシーケンス
  • 転写媒介増幅(TMA)
  • その他

第9章 市場内訳:エンドユーザー別

  • 病院・クリニック
  • リファレンスラボ
  • その他

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bayer AG
    • Becton, Dickinson and Company
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • Qiagen N.V.
    • Siemens Healthcare
    • Sysmex Corporation
図表

List of Figures

  • Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2023
  • Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
  • Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
  • Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Oncology Molecular Diagnostics Market Structure
  • Table 8: Global: Oncology Molecular Diagnostics Market: Key Players
目次
Product Code: SR112024A2396

The global oncology molecular diagnostics market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.1 Billion by 2032, exhibiting a growth rate (CAGR) of 13% during 2024-2032.

Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.

The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology molecular diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on cancer type, product, technology and end-user.

Breakup by Cancer Type:

Breast Cancer

Prostate Cancer

Colorectal Cancer

Cervical Cancer

Liver Cancer

Lung Cancer

Blood Cancer

Others

Breakup by Product:

Instruments

Reagents

Others

Breakup by Technology:

Polymerase Chain Reaction (PCR)

In Situ Hybridization

Chips and Microarrays

Isothermal Nucleic Acid Amplification Technology (INAAT)

Mass Spectrometry

DNA and NGS Sequencing

Transcription Mediated Amplification (TMA)

Others

Breakup by End-User:

Hospitals and Clinics

Reference Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.

Key Questions Answered in This Report:

  • How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncology molecular diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oncology Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Cancer Type

  • 6.1 Breast Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Prostate Cancer
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Colorectal Cancer
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Cervical Cancer
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Liver Cancer
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Lung Cancer
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Blood Cancer
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Polymerase Chain Reaction (PCR)
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In Situ Hybridization
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chips and Microarrays
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Mass Spectrometry
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 DNA and NGS Sequencing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Transcription Mediated Amplification (TMA)
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Others
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Reference Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Becton, Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic, Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Qiagen N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Siemens Healthcare
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis